Evolution of immunity: No development without risk

Immunologic Research

Volumn 52, Issue 3, 2012, Pages 176-181

  Sigalov, Alexander B ^a  

^a SignaBlok Inc   (United States)

Author keywords

Cell receptors; Multichain; Protein intrinsic disorder; Signal transduction; Single chain receptors

Indexed keywords

CELL SURFACE RECEPTOR; IMMUNE RECOGNITION RECEPTOR; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANTIGEN RECOGNITION; ARTICLE; IMMUNE SYSTEM; IMMUNITY; INNATE IMMUNITY; INTRACELLULAR SIGNALING; MOLECULAR EVOLUTION; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SIGNAL TRANSDUCTION; VIRUS;

ANIMALS; BIOLOGICAL EVOLUTION; HUMANS; IMMUNE SYSTEM; RECEPTORS, PATTERN RECOGNITION;

EID: 84864276631     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-011-8256-4     Document Type: Article

References (42)

1. Keegan AD, Paul WE. Multichain immune recognition receptors: similarities in structure and signaling pathways. Immunol Today. 1992;13:63-8.
2. Sigalov AB. Multichain immune recognition receptor signaling: different players, same game? Trends Immunol. 2004;25:583-9.
3. Reth M. Antigen receptor tail clue. Nature. 1989;338:383-4.
4. Wu J, Cherwinski H, Spies T, Phillips JH, Lanier LL. DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells. J Exp Med. 2000;192:1059-68.
5. Sigalov A, Aivazian D, Stern L. Homooligomerization of the cytoplasmic domain of the T cell receptor zeta chain and of other proteins containing the immunoreceptor tyrosine-based activation motif. Biochemistry. 2004;43:2049-61.
6. Sigalov AB, Aivazian DA, Uversky VN, Stern LJ. Lipid-binding activity of intrinsically unstructured cytoplasmic domains of multichain immune recognition receptor signaling subunits. Biochemistry. 2006;45:15731-9.
7. Sigalov AB, Uversky VN. Differential occurrence of protein intrinsic disorder in the cytoplasmic signaling domains of cell receptors. Self Nonself. 2011;2:55-72.
8. Uversky VN. What does it mean to be natively unfolded? Eur J Biochem. 2002;269:2-12.
9. Sigalov AB, Hendricks GM. Membrane binding mode of intrinsically disordered cytoplasmic domains of T cell receptor signaling subunits depends on lipid composition. Biochem Biophys Res Commun. 2009;389:388-93.
10. Sigalov AB, Kim WM, Saline M, Stern LJ. The intrinsically disordered cytoplasmic domain of the T cell receptor zeta chain binds to the nef protein of simian immunodeficiency virus without a disorder-to-order transition. Biochemistry. 2008;47: 12942-4.
11. Sigalov AB, Zhuravleva AV, Orekhov VY. Binding of intrinsically disordered proteins is not necessarily accompanied by a structural transition to a folded form. Biochimie. 2007;89: 419-21.
12. Sigalov AB. The SCHOOL of nature. I. Transmembrane signaling. Self Nonself. 2010;1:4-39.
13. Sigalov AB. New therapeutic strategies targeting transmembrane signal transduction in the immune system. Cell Adh Migr. 2010; 4:255-67.
14. Sigalov AB. Cells diversify transmembrane signaling through the controlled chaos of protein disorder. Self Nonself. 2011;2:75-9.
15. Archakov AI, et al. Protein-protein interactions as a target for drugs in proteomics. Proteomics. 2003;3:380-91.
16. Pagliaro L, et al. Emerging classes of protein-protein interaction inhibitors and new tools for their development. Curr Opin Chem Biol. 2004;8:442-9.
17. Arkin MR, Wells JA. Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nat Rev Drug Discov. 2004;3:301-17.
18. Berg T. Modulation of protein-protein interactions with small organic molecules. Angew Chem Int Ed Engl. 2003;42:2462-81.
19. Fletcher S, Hamilton AD. Protein-protein interaction inhibitors: small molecules from screening techniques. Curr Top Med Chem. 2007;7:922-7.
20. Sigalov AB. Novel mechanistic insights into viral modulation of immune receptor signaling. PLoS Pathog. 2009;5:e1000404.
21. Cohen T, Cohen SJ, Antonovsky N, Cohen IR, Shai Y. HIV-1 gp41 and TCRalpha trans-membrane domains share a motif exploited by the HIV virus to modulate T-cell proliferation. PLoS Pathog. 2010;6:e1001085.
22. Darwin CR. On the origin of species by means of natural selection or The preservation of favoured races in the struggle for life. London: John Murray; 1861.
23. Dyson HJ, Wright PE. Intrinsically unstructured proteins and their functions. Nat Rev Mol Cell Biol. 2005;6:197-208.
24. Iakoucheva LM, Brown CJ, Lawson JD, Obradovic Z, Dunker AK. Intrinsic disorder in cell-signaling and cancer-associated proteins. J Mol Biol. 2002;323:573-84.
25. Minezaki Y, Homma K, Nishikawa K. Intrinsically disordered regions of human plasma membrane proteins preferentially occur in the cytoplasmic segment. J Mol Biol. 2007;368:902-13.
26. Sickmeier M, et al. DisProt: the database of disordered proteins. Nucleic Acids Res. 2007;35:D786-93.
27. Patil A, Nakamura H. Disordered domains and high surface charge confer hubs with the ability to interact with multiple proteins in interaction networks. FEBS Lett. 2006;580:2041-5.
28. Pitcher LA, van Oers NS. T-cell receptor signal transmission: who gives an ITAM? Trends Immunol. 2003;24:554-60.
29. Pike KA, Baig E, Ratcliffe MJ. The avian B-cell receptor complex: distinct roles of Igalpha and Igbeta in B-cell development. Immunol Rev. 2004;197:10-25.
30. Storch B, Meixlsperger S, Jumaa H. The Ig-alpha ITAM is required for efficient differentiation but not proliferation of pre-B cells. Eur J Immunol. 2007;37:252-60.
31. Sanchez-Mejorada G, Rosales C. Signal transduction by immunoglobulin Fc receptors. J Leukoc Biol. 1998;63:521-33.
32. Jensen WA, Pleiman CM, Beaufils P, Wegener AM, Malissen B, Cambier JC. Qualitatively distinct signaling through T cell antigen receptor subunits. Eur J Immunol. 1997;27:707-16.
33. Chae WJ, et al. Qualitatively differential regulation of T cell activation and apoptosis by T cell receptor zeta chain ITAMs and their tyrosine residues. Int Immunol. 2004;16:1225-36.
34. Borghesi L, Milcarek C. Innate versus adaptive immunity: a paradigm past its prime? Cancer Res. 2007;67:3989-93.
35. Janeway C. Immunobiology: the immune system in health and disease. New York: Garland Science; 2005. p. 823.
36. Kimbrell DA, Beutler B. The evolution and genetics of innate immunity. Nat Rev Genet. 2001;2:256-67.
37. Cooper MD, Alder MN. The evolution of adaptive immune systems. Cell. 2006;124:815-22.
38. Litman GW, Cooper MD. Why study the evolution of immunity? Nat Immunol. 2007;8:547-8.
39. Roifman CM. CD3 delta immunodeficiency. Curr Opin Allergy Clin Immunol. 2004;4:479-84.
40. Sun JC, Lanier LL. Natural killer cells remember: an evolutionary bridge between innate and adaptive immunity? Eur J Immunol. 2009;39:2059-64.
41. Galimov EM. Phenomenon of life: between equilibrium and nonlinearity. Orig Life Evol Biosph. 2004;34:599-613.
42. Sigalov AB. Interaction between HIV gp41 fusion peptide and T cell receptor: putting the puzzle pieces back together. Faseb J. 2007; 21:1633-1634; author reply 1635.